AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Cholesterol-lowering drugs generally reduce cardiovascular events by 35%. Those rates ought to be better, said Dr. H. Bryan Brewer Jr., chief of the molecular disease branch at the National Heart, Lung, and Blood Institute, Bethesda, Md.
He attributed this shortfall to compliance and access issues, as well as to the statins' relatively one-dimensional approach of lowering LDL.
Triglyceride levels might be the bigger issue for patients with diabetes or the "metabolic syndrome" of abdominal obesity, triglyceride levels above 150 mg/dL, HDL levels below 40 mg/dL for men and 50 mg/dL for women, and blood pressure above 130/85 mm Hg.
There may be "good" and "bad" triglycerides, Dr. ...